Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 5, 1999, Pages 637-643

  Nishijima, Toshio ^a   Saito, Yasuyoshi ^a   Aoki, Akiko ^a   Toriya, Minoru ^a   Toyonaga, Yoshihiko ^b   Fujii, Ryochi ^c  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

^b Yamanashi Red Cross Hospital   (Japan)

^c Chemother Mothers Children Res I   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; OLEANDOMYCIN; PENICILLIN G; ROKITAMYCIN; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CORRELATION FUNCTION; HUMAN; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032950887     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.5.637     Document Type: Article

References (16)

1. Washington, J. A. & Wilson, W. R. (1985). Erythromycin: amicrobial and clinical perspective after 30 years of clinical use (2). Mayo Clinic Proceedings 60, 271-8.
2. Jones, W. F., Nichols, R. L. & Finland, M. (1956). Development of resistance and cross-resistance in-vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin. Proceedings of the Society for Experimental Biology and Medicine 93, 388-93.
3. Weisblum, B. (1985). Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression. A review. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 63-90.
4. Jenssen, W. D., Thakker-Varia, S., Dubin, D. T. & Weinstein, M. P. (1987). Prevalence of macrolide-lincosamide-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrobial Agents and Chemotherapy 31, 883-8.
5. Janosi, L. & Ban, E. (1982). Localization of the gene(s) determining inducible type macrolide and streptogramin B resistance on the penicillinase plasmid of isolates of an epidemic Staphylococcus aureus strain. In Current Chemotherapy and Immunotherapy, Vol. II. Proceedings of the Twelfth International Congress of Chemotherapy, Florence, Italy, 1981. (Periti, P. & Grassi, G. G., Eds), pp. 918-9. American Society for Microbiology, Washington, DC.
6. Ross, J. I., Farrell, A. M., Eady, E. A., Cove, J. H. & Cunliffe, W. J. (1989). Characterization and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy 24, 851-62.
7. Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J., Baumberg, S. & Wootton, J. C. (1990). Inducible erythromycin resistance in stapylococci is encoded by member of the ATP-binding transport supergene family. Molecular Microbiology 4, 1207-14.
8. Konno, M., Yoshida, S., Inoue, M., Shimizu, Y., Akizawa, K. & Vehara, N. (1994). An epidemiological study of penicillin-resistant Streptococcus pneumoniae in Japan. Yearly changes in isolation frequencies from clinical specimens, serotype distributions and drug susceptibilities, especially those of β-lactam-resistant strains. Kansenshogaku Zasshi 68, 1338-51.
9. Oguri, T. (1996). Clinical and bacteriological studies of Streptococcus pneumoniae. Japanese Journal of Antibiotics 39, 783-805.
10. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
11. Tait-Kamradt, A., Clancy, J., Cronan, M., Dib-Haji, F., Wondrack, L., Yuan, W. et al. (1997). mefE is necessary for erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 41, 2251-5.
12. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
13. Nawaz, M. S., Khan, A. A. & Cerniglia, C. E. (1997). Detection of erythromycin resistant methylase gene by the polymerase chain reaction. Molecular and Cellular Probes 11, 317-22.
14. Toyonaga, Y. & Fujii, R. (1996). Session No. 64009. Clinical and bacteriological efficacy of rokitamycin compared with cefditoren and cefdinir in children with pneumococcal upper respiratory tract infections. Presented at Seventh International Congress for Infectious Diseases. Hong Kong.
15. Committee for Revision of MIC Determination Method. (1981). Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy 29, 76-9.
16. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Third Edition: Approved Standard M7-A3. NCCLS, Villanova, PA.